Corcept Therapeutics (CORT) Change in Inventory (2012 - 2026)

Corcept Therapeutics has disclosed Change in Inventory across 15 years of filings, most recently posting $3.3 million for Q1 2026.

• Change in Inventory for Q1 2026 came in at $3.3 million, up 640.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.4 million (up 15458.9% YoY), and the FY2025 annual result was $7.5 million, up 2552.79% from the prior year.
• Change in Inventory came in at $3.3 million for Q1 2026 at Corcept Therapeutics, up from -$483000.0 in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $4.6 million in Q2 2025 to a low of -$1.1 million in Q3 2024.
• The 5-year median for Change in Inventory is -$329000.0 (2023), against an average of $469647.1.
• Across the five-year window, Change in Inventory sank 719.23% in 2025 and surged 640.83% in 2026, its largest moves.
• Corcept Therapeutics' Change in Inventory stood at -$125000.0 in 2022, then tumbled by 163.2% to -$329000.0 in 2023, then jumped by 123.71% to $78000.0 in 2024, then tumbled by 719.23% to -$483000.0 in 2025, then jumped by 777.43% to $3.3 million in 2026.
• The last three Change in Inventory figures came in at $3.3 million (Q1 2026), -$483000.0 (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.